Farhad Islami1, Ann Goding Sauer1, Susan M Gapstur2, Ahmedin Jemal1. 1. Surveillance and Health Services Research, American Cancer Society, Atlanta, Georgia. 2. Epidemiology Research Program, American Cancer Society, Atlanta, Georgia.
Abstract
Importance: Excess body weight (EBW) is an established cause of cancer. Despite variations in the prevalence of EBW among US states, there is little information on the EBW-related cancer burden by state; this information would be useful for setting priorities for cancer-control initiatives. Objective: To calculate the population attributable fraction (PAF) of incident cancer cases attributable to EBW among adults 30 years or older in 2011 to 2015 in all 50 states and the District of Columbia. Design, Setting, and Participants: State-level, self-reported body mass index (BMI [calculated as weight in kilograms divided by height in meters squared]) data from the Behavioral Risk Factor Surveillance System were adjusted by sex, age, race/ethnicity, and education using objectively measured BMI values from the National Health and Nutrition Examination Survey. Age- and sex-specific cancer incidence data by state were obtained from the US Cancer Statistics database. All analyses were performed between February 15, 2018, and July 17, 2018. Main Outcomes and Measures: Sex-, age-, and state-specific adjusted prevalence estimates for 4 high BMI categories and corresponding relative risks from large-scale pooled analyses or meta-analyses were used to compute the PAFs for each US state for esophageal adenocarcinoma, multiple myeloma, and cancers of the gastric cardia, colorectum, liver, gallbladder, pancreas, female breast, corpus uteri, ovary, kidney and renal pelvis, and thyroid. Results: Each year, an estimated 37 670 cancer cases in men (4.7% of all cancer cases excluding nonmelanoma skin cancers) and 74 690 cancer cases in women (9.6%) 30 years or older in the United States were attributable to EBW from 2011 to 2015. In both men and women, there was at least a 1.5-fold difference in the proportions of cancers attributable to EBW between states with the highest and lowest PAFs. Among men, the PAF ranged from 3.9% (95% CI, 3.6%-4.3%) in Montana to 6.0% (95% CI, 5.6%-6.4%) in Texas. The PAF for women was approximately twice as high as for men, ranging from 7.1% (95% CI, 6.7%-7.6%) in Hawaii to 11.4% (95% CI, 10.7%-12.2%) in the District of Columbia. The largest PAFs were found mostly in southern and midwestern states, as well as Alaska and the District of Columbia. Conclusions and Relevance: The proportion of cancers attributable to EBW varies among states, but EBW accounts for at least 1 in 17 of all incident cancers in each state. Broad implementation of known community- and individual-level interventions is needed to reduce access to and marketing of unhealthy foods (eg, through a tax on sugary drinks) and to promote and increase access to healthy foods and physical activity, as well as preventive care.
Importance: Excess body weight (EBW) is an established cause of cancer. Despite variations in the prevalence of EBW among US states, there is little information on the EBW-related cancer burden by state; this information would be useful for setting priorities for cancer-control initiatives. Objective: To calculate the population attributable fraction (PAF) of incident cancer cases attributable to EBW among adults 30 years or older in 2011 to 2015 in all 50 states and the District of Columbia. Design, Setting, and Participants: State-level, self-reported body mass index (BMI [calculated as weight in kilograms divided by height in meters squared]) data from the Behavioral Risk Factor Surveillance System were adjusted by sex, age, race/ethnicity, and education using objectively measured BMI values from the National Health and Nutrition Examination Survey. Age- and sex-specific cancer incidence data by state were obtained from the US Cancer Statistics database. All analyses were performed between February 15, 2018, and July 17, 2018. Main Outcomes and Measures: Sex-, age-, and state-specific adjusted prevalence estimates for 4 high BMI categories and corresponding relative risks from large-scale pooled analyses or meta-analyses were used to compute the PAFs for each US state for esophageal adenocarcinoma, multiple myeloma, and cancers of the gastric cardia, colorectum, liver, gallbladder, pancreas, female breast, corpus uteri, ovary, kidney and renal pelvis, and thyroid. Results: Each year, an estimated 37 670 cancer cases in men (4.7% of all cancer cases excluding nonmelanoma skin cancers) and 74 690 cancer cases in women (9.6%) 30 years or older in the United States were attributable to EBW from 2011 to 2015. In both men and women, there was at least a 1.5-fold difference in the proportions of cancers attributable to EBW between states with the highest and lowest PAFs. Among men, the PAF ranged from 3.9% (95% CI, 3.6%-4.3%) in Montana to 6.0% (95% CI, 5.6%-6.4%) in Texas. The PAF for women was approximately twice as high as for men, ranging from 7.1% (95% CI, 6.7%-7.6%) in Hawaii to 11.4% (95% CI, 10.7%-12.2%) in the District of Columbia. The largest PAFs were found mostly in southern and midwestern states, as well as Alaska and the District of Columbia. Conclusions and Relevance: The proportion of cancers attributable to EBW varies among states, but EBW accounts for at least 1 in 17 of all incident cancers in each state. Broad implementation of known community- and individual-level interventions is needed to reduce access to and marketing of unhealthy foods (eg, through a tax on sugary drinks) and to promote and increase access to healthy foods and physical activity, as well as preventive care.
Authors: Ali H Mokdad; Katherine Ballestros; Michelle Echko; Scott Glenn; Helen E Olsen; Erin Mullany; Alex Lee; Abdur Rahman Khan; Alireza Ahmadi; Alize J Ferrari; Amir Kasaeian; Andrea Werdecker; Austin Carter; Ben Zipkin; Benn Sartorius; Berrin Serdar; Bryan L Sykes; Chris Troeger; Christina Fitzmaurice; Colin D Rehm; Damian Santomauro; Daniel Kim; Danny Colombara; David C Schwebel; Derrick Tsoi; Dhaval Kolte; Elaine Nsoesie; Emma Nichols; Eyal Oren; Fiona J Charlson; George C Patton; Gregory A Roth; H Dean Hosgood; Harvey A Whiteford; Hmwe Kyu; Holly E Erskine; Hsiang Huang; Ira Martopullo; Jasvinder A Singh; Jean B Nachega; Juan R Sanabria; Kaja Abbas; Kanyin Ong; Karen Tabb; Kristopher J Krohn; Leslie Cornaby; Louisa Degenhardt; Mark Moses; Maryam Farvid; Max Griswold; Michael Criqui; Michelle Bell; Minh Nguyen; Mitch Wallin; Mojde Mirarefin; Mostafa Qorbani; Mustafa Younis; Nancy Fullman; Patrick Liu; Paul Briant; Philimon Gona; Rasmus Havmoller; Ricky Leung; Ruth Kimokoti; Shahrzad Bazargan-Hejazi; Simon I Hay; Simon Yadgir; Stan Biryukov; Stein Emil Vollset; Tahiya Alam; Tahvi Frank; Talha Farid; Ted Miller; Theo Vos; Till Bärnighausen; Tsegaye Telwelde Gebrehiwot; Yuichiro Yano; Ziyad Al-Aly; Alem Mehari; Alexis Handal; Amit Kandel; Ben Anderson; Brian Biroscak; Dariush Mozaffarian; E Ray Dorsey; Eric L Ding; Eun-Kee Park; Gregory Wagner; Guoqing Hu; Honglei Chen; Jacob E Sunshine; Jagdish Khubchandani; Janet Leasher; Janni Leung; Joshua Salomon; Jurgen Unutzer; Leah Cahill; Leslie Cooper; Masako Horino; Michael Brauer; Nicholas Breitborde; Peter Hotez; Roman Topor-Madry; Samir Soneji; Saverio Stranges; Spencer James; Stephen Amrock; Sudha Jayaraman; Tejas Patel; Tomi Akinyemiju; Vegard Skirbekk; Yohannes Kinfu; Zulfiqar Bhutta; Jost B Jonas; Christopher J L Murray Journal: JAMA Date: 2018-04-10 Impact factor: 56.272
Authors: Marjorie L McCullough; Alpa V Patel; Lawrence H Kushi; Roshni Patel; Walter C Willett; Colleen Doyle; Michael J Thun; Susan M Gapstur Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-04-05 Impact factor: 4.254
Authors: Jeanine M Genkinger; Donna Spiegelman; Kristin E Anderson; Leslie Bernstein; Piet A van den Brandt; Eugenia E Calle; Dallas R English; Aaron R Folsom; Jo L Freudenheim; Charles S Fuchs; Graham G Giles; Edward Giovannucci; Pamela L Horn-Ross; Susanna C Larsson; Michael Leitzmann; Satu Männistö; James R Marshall; Anthony B Miller; Alpa V Patel; Thomas E Rohan; Rachael Z Stolzenberg-Solomon; Bas A J Verhage; Jarmo Virtamo; Bradley J Willcox; Alicja Wolk; Regina G Ziegler; Stephanie A Smith-Warner Journal: Int J Cancer Date: 2011-03-04 Impact factor: 7.396
Authors: Corinna Hawkes; Trenton G Smith; Jo Jewell; Jane Wardle; Ross A Hammond; Sharon Friel; Anne Marie Thow; Juliana Kain Journal: Lancet Date: 2015-02-19 Impact factor: 79.321
Authors: Anh Le; Suzanne E Judd; David B Allison; Reena Oza-Frank; Olivia Affuso; Monika M Safford; Virginia J Howard; George Howard Journal: Obesity (Silver Spring) Date: 2013-06-13 Impact factor: 5.002
Authors: Brittny C Davis Lynn; Pavel Chernyavskiy; Gretchen L Gierach; Philip S Rosenberg Journal: J Natl Cancer Inst Date: 2022-09-09 Impact factor: 11.816
Authors: Heather M Ochs-Balcom; Priyanka Kanth; James M Farnham; Samir Abdelrahman; Lisa A Cannon-Albright Journal: Genet Epidemiol Date: 2020-07-16 Impact factor: 2.135
Authors: Heather Spencer Feigelson; Clara Bodelon; J David Powers; Rochelle E Curtis; Diana S M Buist; Lene H S Veiga; Erin J Aiello Bowles; Amy Berrington de Gonzalez; Gretchen L Gierach Journal: J Natl Cancer Inst Date: 2021-09-04 Impact factor: 13.506
Authors: Alison E Ringel; Jefte M Drijvers; Gregory J Baker; Alessia Catozzi; Juan C García-Cañaveras; Brandon M Gassaway; Brian C Miller; Vikram R Juneja; Thao H Nguyen; Shakchhi Joshi; Cong-Hui Yao; Haejin Yoon; Peter T Sage; Martin W LaFleur; Justin D Trombley; Connor A Jacobson; Zoltan Maliga; Steven P Gygi; Peter K Sorger; Joshua D Rabinowitz; Arlene H Sharpe; Marcia C Haigis Journal: Cell Date: 2020-12-09 Impact factor: 41.582
Authors: Siegfried Janz; Fenghuang Zhan; Fumou Sun; Yan Cheng; Michael Pisano; Ye Yang; Hartmut Goldschmidt; Parameswaran Hari Journal: Front Genet Date: 2019-05-08 Impact factor: 4.599
Authors: Justin Xavier Moore; Stephen J Carter; Victoria Williams; Saira Khan; Marquita W Lewis-Thames; Keon Gilbert; George Howard Journal: Prev Med Date: 2020-01-16 Impact factor: 4.018
Authors: Shao-Ming Wang; Hormuzd A Katki; Barry I Graubard; Lisa L Kahle; Anil Chaturvedi; Charles E Matthews; Neal D Freedman; Christian C Abnet Journal: Am J Gastroenterol Date: 2021-09-01 Impact factor: 12.045